Top Markets
Coin of the day
Eagle Pharmaceuticals, Inc. Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.

EGRX
Rangering i aksjer #33346
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on... Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company’s product portfolio offers RYANODEX for malignant hyperthermia; and BELRAPZO and BENDEKA for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma. It also produces PEMFEXY, a ready-to-dilute liquid form of pemetrexed injection, indicated in combination with cisplatin for the initial treatment of patients with malignant pleural mesothelioma and non-small cell lung cancer; BARHEMSYS, a selective dopamine-2 (D2) and dopamine-3 (D3) receptor antagonist indicated in adults for prevention of postoperative nausea and vomiting (PONV); BYFAVO, a benzodiazepine indicated for the induction and maintenance of procedural sedation in adults. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an anti-toxin agent in Phase 2 development for the treatment of severe pneumonia in combination with traditional antibacterial drugs; ENA-001 developed by Enalare, an agnostic respiratory stimulant for respiratory depression; EA-114, novel and proprietary formulation of fulvestrant developed for hormone-receptor-positive (HR+) metastatic breast cancer. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat cancer. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Aksjekurs
$0.595
Sist synkronisert: 2026-08-13
Markedsverdi
$7.83M
Endring (1 dag)
0.00%
Endring (1 år)
-81.41%
Land
US
Handel Eagle Pharmaceuticals, Inc. (EGRX)

Kategori

Aksjeprishistorikk for Eagle Pharmaceuticals, Inc. (EGRX)
Høyeste sluttskurs: $0.27 den 2026-08-01

Laveste sluttskurs: $12.89 den 2014-02-01
Aksjeprishistorikk for Eagle Pharmaceuticals, Inc. fra 2014 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 96.79%
2025 -29.61%
2024 -87.52%
2023 -82.65%
2022 -38.74%
2021 7.84%
2020 -20.71%
2019 39.37%
2018 -25.22%
2017 -26.15%
2016 -16.70%
2015 591.76%
2014 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$171.67 -
DE
$161.85 23.39%
DE
$35.97 20.03%
JP
$222.98 36.28%
CH
$20.77 10.96%
IN